Vaccine Costs Aren’t Likely to Break the Banks of Corporate Health Plan Sponsors
The New York Times (NYT) reported that 13 vaccines are currently in the final stages of testing. Phase 1 testing involves a small sample of people to test safety, dosage, and confirm that the immune system is stimulated by the drug. Phase 2 increases the sample to hundreds of people, testing further for safety/efficacy, and segments the test group to see if different populations experience different outcomes. Phase 3 involves thousands of patients, some of whom receive a placebo. Along the path toward approval, testing may be halted in the event adverse or unexpected outcomes are noted. This has …
https://www.epicbrokers.com/insights/vaccine-costs-arent-likely-to-break-the-banks-of-corporate-health-plan-sponsors/